参考文献/References:
[1] Brown ZJ,Tsilimigras DI,Ruff SM,et al.Management of hepatocellular carcinoma:a review[J].JAMA Surg,2023,158:410-420.
[2]张小强,邓 英,李 锐,等.经皮射频消融与手术切除治疗直径≤3 cm原发性小肝癌的疗效分析[J].中国现代医学杂志,2023,33:8-12.
Zhang XQ,Deng Y,Li R,et al.Efficacy of percutaneous radiofrequency ablation versus surgical resection for primary small hepatocellular carcinoma ≤ 3 cm in diameter[J].China J Mod Med,2023,33:8-12.
[3]Liu B,Zhang Y,Chen H,et al.The combination of transcatheter arterial chemoembolisation(TACE)and thermal ablation versus TACE alone for hepatocellular carcinoma[J].Cochrane Database Syst Rev,2022,1:CD013345.
[4]郭玮平,王 杰,祖庆泉,等.肝动脉化疗栓塞联合透视引导下微波消融治疗小肝癌[J].实用放射学杂志,2019,35:1307-1310.
Guo WP,Wang J,Zu QQ,et al.Transarterial chemoembolization combined with fluoroscopy-guided microwave ablation for small hepatocellular carcinoma[J].J Pract Radiol,2019,35:1307-1310.
[5]Kim DK,Han K,Won JY,et al.Percutaneous cryoablation in early stage hepatocellular carcinoma:analysis of local tumor progression factors[J].Diagn Interv Radiol,2020,26:111-117.
[6]Llovet JM,Lencioni R.mRECIST for HCC:Performance and novel refinements[J].J Hepatol,2020,72:288-306.
[7]Ji J,Yang W,Shi HB,et al.Transcatheter arterial chemoembolization alone versus combined with microwave ablation for recurrent small hepatocellular carcinoma after resection:a retrospective comparative study[J].BMC Gastroenterol,2022,22:321.
[8]孟兆阳,蒲江波,李向宁.基于光遗传学技术的脑机接口研究进展[J].中国生物医学工程学报,2024,43:204-213.
Meng ZY,Pu JB,Li XN,et al.Research progress of optogenetic brain-computer interface[J].Chin J Biomed Eng,2024,43:204-213.
[9]Ko SE,Lee MW,Rhim H,et al.Comparison of procedure-related complications between percutaneous cryoablation and radiofrequency ablation for treating periductal hepatocellular carcinoma[J].Int J Hyperthermia,2020,37:1354-1361.
[10]Yang W,An Y,Li Q,et al.Co-ablation versus cryoablation for the treatment of stage Ⅲ-Ⅳ non-small cell lung cancer:A prospective,noninferiority,randomized,controlled trial(RCT)[J].Thorac Cancer,2021,12:475-483.
[11]戴文燕,覃玉冰,赵一帆.氩氦刀局部冷冻消融联合全身疗法治疗晚期乳腺癌侵犯皮肤致破溃、出血[J].中国介入影像与治疗学,2022,19:729-731.
Dai WY,Qin YB,Zhao YF,et al.Argon-helium local cryoablation combined with systemic therapy for advanced breast cancer with skin invasion causing ulceration and hemorrhage[J].Chin J Intervent Imaging Ther,2022,19:729-731.
[12]杨海明,孙世蒙,于海东,等.TACE联合氩氦刀冷冻治疗中晚期原发性肝癌的安全性和疗效分析[J].实用放射学杂志,2019,35:444-447.
Yang HM,Sun SM,Yu HD,et al.The safety and efficacy of transcatheter arterial chemoembolization combined with argon-helium cryosurgery in the treatment of advanced primary liver cancer[J].Journal of Practical Radiology,2019,35:444-447.
[13]李 新,许家健,邓婉芳,等.氩氦刀冷冻消融联合经导管肝动脉化疗栓塞治疗肝细胞癌[J].肿瘤基础与临床,2019,32:126-129.
Li X,Xu JJ,Deng WF,et al.Argon-helium cryoablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma[J].J Basic Clin Oncol,2019,32:126-129.
[14]Cheng JF,Sun QL,Tang L,et al.Meta-analysis of transarterial chemoembolization combined with cryoablation vs transarterial chemoembolization alone for ≥ 5 cm hepatocellular carcinoma[J].World J Gastrointest Oncol,2024,16:2793-2803.
[15]李 睿,史勤生.氩氦刀联合肝动脉栓塞化疗在不可手术的中晚期肝癌患者中的疗效分析[J].肝脏,2020,25:919-921.
Li R,Shi QS.An Analysis on the efficacy of combination therapy with argon-helium knife cryoablation and transcatheter hepatic arterial chemoembolization for unoperable patients with advanced liver cancers[J].Chin Hepatol,2020,25:919-921.
[16]徐 伟,王 霞,武子英,等.经导管动脉化疗栓塞术联合冷冻消融治疗不可切除性大肝癌患者的效果及对细胞免疫的影响[J].中国肿瘤临床与康复,2019,26:1039-1042.
Xu W,Wang X,Wu ZY,et al.Efficacy of transcatheter arterial chemoembolization combined with cryoablation for unresectable large hepatocellular carcinoma and the effect on cellular immunity[J].Chin J Clin Oncol Rehabil,2019,26:1039-1042.
[17]魏庭丰,何仕诚,朱海东,等.原发性肝癌肝动脉化疗栓塞治疗间隔长短对近期肝功能影响的比较[J].介入放射学杂志,2020,29:1126-1130.
Wei TF,He SC,Zhu HD,et al.The impact of different intervals between two TACE procedures on the short-term liver functions in patients with hepatocellular carcinoma[J].J Intervent Radiol,2020,29:1126-1130.
[18]向 姣,贾晓东,卢姗姗,等.冷冻消融与微波消融治疗对肝细胞癌患者临床指标和细胞因子的影响[J].临床肝胆病杂志,2019,35:1728-1733.
Xiang J,Jia XD,Lu SS,et al.Effect of cryoablation versus microwave ablation on clinical indices and cytokines in patients with hepatocellular carcinoma[J].J Clin Hepatol,2019,35:1728-1733.
[19]Wang J,Huang A,Fu P,et al.Effects of TACE combined with microwave ablation on T lymphocyte subsets and prognosis in patients with liver cancer and analysis of safety[J].J BUON,2020,25:1883-1889.
[20]罗 剑,盛文飞,马佳铭,等.氩氦刀冷冻消融联合TACE治疗巨大肝癌对免疫功能的影响[J].中华普外科手术学杂志(电子版),2021,15:298-301.
Luo J,Sheng WF,Ma JM,et al.The effect on immune function of patients with huge liver cancer by argon-helium knife cryoablation combined with TACE[J].Chin J Oper Proc Gen Surg(Electron Ed),2021,15:298-301.
[21]谭 鑫,王高兴,王 佳,等.氩氦刀并肝动脉介入治疗原发性肝癌及对血清VEGF及MMP的影响研究[J].临床和实验医学杂志,2021,20:493-496.
Tan X,Wang GX,Wang J,et al.Study on argon-helium knife combined with hepatic artery interventional therapy for primary hepatic carcinoma and its effect on serum VEGF and MMP[J].J Clin Exp Med,2021,20:493-496.
[22]刘建平,熊 勇,范耀刚,等.微波消融联合经肝动脉化疗栓塞术对肝癌患者免疫功能、AFP水平及生存时间的影响[J].中国老年学杂志,2018,38:554-556.
Liu JP,Xiong Y,Fan YG,et al.Effects of microwave ablation combined with transcatheter arterial chemoembolization on immune function,AFP level and survival time in patients with liver cancer[J].Chin J Gerontol,2018,38:554-556.
[23]Zhang K,Liu M,Cong L,et al.A Comparative study of antitumor immunity induced by radiofrequency microwave and cryoablation in hepatocellular carcinoma[J].Appl Biochem Biotechnol,2024,196:4088-4104.
[24]Tayob N,Kanwal F,Alsarraj A,et al.The Performance of AFP,AFP-3,DCP as biomarkers for detection of hepatocellular carcinoma(HCC):a phase 3 biomarker study in the united states[J].Clin Gastroenterol Hepatol,2023,21:415-423.e4.
[25]Gu D,Xie Y,Wei J,et al.MRI-based radiomics signature:A potential biomarker for identifying glypican 3-positive hepatocellular carcinoma[J].J Magn Reson Imaging,2020,52:1679-1687.
[26]宋红亮,王建国,张 会,等.血清学标志物甲胎蛋白、PIVKA-Ⅱ和磷脂酰肌醇蛋白聚糖3联合诊断肝癌的meta分析[J].浙江大学学报(医学版),2024,53:131-139.
Song HL,Wang JG,Zhang H,et al.Combination of serum alpha-fetoprotein,PIVKA-Ⅱ and glypican-3 in diagnosis of hepatocellular carcinoma:a meta-analysis[J].J Zhejiang Univ(Med Sci),2024,53:131-139.
[27]罗 斌,洪 梅,李 波.TACE联合氩氦刀冷冻消融对中晚期肝癌的疗效及对MIF、VEGF、GP73、AFP表达水平的影响[J].现代肿瘤医学,2019,27:3082-3086.
Luo B,Hong M,Li B.Effect of TACE combined with cryosurgery on serum MIF,VEGF,GP73 and AFP levels in patients with middle and advanced liver cancer[J].J Mod Oncol,2019,27:3082-3086.
(收稿日期:2024-11-28)
(本文编辑:谷 珂)
相似文献/References:
[1]张 磊,陆骊工,李 勇,等.门静脉支架联合肝动脉化疗栓塞治疗肝癌伴门静脉癌栓的临床研究[J].介入放射学杂志,2011,(12):968.
ZHANG Lei,LU Li-gong,LI Yong,et al.Portal vein stent placement combined with TACE for the treatment of hepatocellular carcinoma associated with tumor thrombus in portal vein[J].J Intervent Med,2011,(08):968.
[2]沈海洋,刘瑞宝,刘 岩,等. 肝右叶前、后段原发性肝癌TACE后VEGF及CD34的表达水平 ；[J].介入放射学杂志,2012,(06):469.
SHEN Hai- yang,LIU Rui- bao,LIU Yan,et al. The expression levels of vascular endothelial growth factor and CD34 in residual cancerous tissues of primary hepatocellular carcinoma located at anterior and posterior segments of right lobe liver after TACE[J].J Intervent Med,2012,(08):469.
[3]孙世蒙,郭应兴,雷振武,等.TACE治疗原发性肝癌伴门静脉癌栓研究进展 [J].介入放射学杂志,2017,(07):668.
SUN Shimeng,GUO Yingxing,LEI Zhenwu,et al.TACE for the treatment of primary hepatocellular carcinoma associated with portal vein tumor thrombus： recent progress in research[J].J Intervent Med,2017,(08):668.
[4]王 龙,张 勇,王亚运,等.125I粒子联合经导管动脉化疗栓塞治疗肝细胞肝癌伴门静脉癌栓临床有效性与安全性meta 分析[J].介入放射学杂志,2018,27(05):419.
WANG Long,ZHANG Yong,WANG Yayun,et al.125I seed implantation combined with TACE for the treatment of HCC complicated by portal vein tumor thrombus： a meta- analysis of its clinical effectiveness and safety[J].J Intervent Med,2018,27(08):419.
[5]翟越,赵 卫,潘文秋,等.TACE联合载药微球治疗肝癌的研究进展[J].介入放射学杂志,2019,28(12):1211.
ZHAI Yue,ZHAO Wei,PAN Wenqiu,et al.TACE combined with drug- eluting beads for the treatment of hepatocellular carcinoma： recent progress in research[J].J Intervent Med,2019,28(08):1211.
[6]陆一峰,王 祁,何忠明.肝细胞癌患者微创治疗后复发评分系统的建立及验证[J].介入放射学杂志,2020,29(12):1207.
LU Yifeng,WANG Qi,HE Zhongming..Establishment and verification of recurrence scoring system for patients with hepatocellular carcinoma after minimally-invasive treatment[J].J Intervent Med,2020,29(08):1207.
[7]徐李刚,张 巍,钱 晟,等.经导管动脉化疗栓塞成功转化的初始不可切除肝癌术前预测模型的临床研究[J].介入放射学杂志,2022,31(07):670.
XU Ligang,ZHANG Wei,QIAN Sheng,et al.The establishment of preoperative predictive model used for predicting TACE-transformed initially-inoperable HCC： a clinical study[J].J Intervent Med,2022,31(08):670.
[8]郝晓光,李伟靖,朱丽娜,等.中晚期肝癌患者经导管化疗栓塞治疗后序贯射频消融手术治疗时机的选择[J].介入放射学杂志,2022,31(09):908.
HAO Xiaoguang,LI Weijing,ZHU Lina,et al.Optimal timing of sequential radiofrequency ablation treatment in patients with advanced liver cancer after receiving transcatheter chemoembolization[J].J Intervent Med,2022,31(08):908.
[9]游建雄,王精兵,蒋春雨,等.经导管动脉化疗栓塞联合CT引导下125Ι放射性粒子植入治疗晚期头颈部癌伴出血的疗效分析[J].介入放射学杂志,2023,32(06):569.
YOU Jianxiong,WANG Jingbing,JIANG Chunyu,et al.Transcatheter arterial chemoembolization combined with CT-guided interstitial 125Ι seeds implantation for advanced head and neck cancer associated with hemorrhage： analysis of its efficacy[J].J Intervent Med,2023,32(08):569.
[10]黄叶才,周 杰,张 鹏,等.大分割放疗联合经导管动脉化疗栓塞治疗鼻咽癌异时性肝寡转移临床效果分析[J].介入放射学杂志,2025,34(09):992.[doi:10.3969/j.issn.1008-794X.2025.09.015]
HUANG Yecai,ZHOU Jie,ZHANG Peng,et al.Hypofractionated radiotherapy combined with transcatheter arterial chemoembolization for the treatment of metachronous hepatic oligometastasis from nasopharyngeal carcinoma:analysis of its clinical effect[J].J Intervent Med,2025,34(08):992.[doi:10.3969/j.issn.1008-794X.2025.09.015]